MONITORING OF METABOLIC PARAMETERS IN DIABETES MELLITUS: SOME PROBLEMS AND METHODS OF THEIR SOLUTION
Keywords:diabetes mellitus, self-monitoring, glucometer, ketone bodies
Today the necessity of achieving a stable normalization of metabolic disorders in diabetes mellitus (DM)
is justified. The indicated is impossible without without patient self-monitoring activities. The measurement
of glycemia using glucometers is recognized as extremely important. It is quite clear that the readings of the
glucometer are clear guidelines, and incorrect data can lead to erroneous actions by the patient. Therefore,
measurement accuracy should be an integral characteristic of the device. There are often situations when difficulties arising from the operation of the glucometers reduce the motivation to conduct self-monitoring measures
with the subsequent possible refusal of the patient to determine glycemia in general. To prevent this situation,
the instruction manual should be understandable, and the glucometer must have a simple coding or no need to
enter a code. In addition, the glucometer should have a convenient size with the ability to determine the level
of glycemia in any unforeseen situation. The reading process of results should not be an obstacle for a patient
with a decrease in visual acuity. In modern glucometers, this is ensured by the presence of a certain size display with backlight. At the same time, test strips should be designed so that the patient, even in the presence
of severe disturbances in tactile sensitivity, can confidently hold and clearly identify their front and back sides.
It is important to provide the glucometers with a certain amount of memory. BIONIME Rightest® GM550 and
BIONIME Rightest® GM110 glucometers are recognized as devices that meet modern requirements. In addition to blood sugar indicators, effective self-monitoring involves the determination of ketone bodies in the urine,
which in outpatient settings is quite affordable through the use of special test-strips Express Test (test for determining ketones).
Nathan DM. Diabetes Care. 2014; 37(1): 9-16. doi: http://doi.org/10.2337/dc13-2112.
Keng MJ, Tsiachristas A, Leal J, et al. Diabetes Obes Metab. 2019; 2. doi: http://doi.org/10.1111/dom.13821.
Testa R, Bonfigli AR, Prattichizzo F, et al. Nutrients. 2017; 9(5): 437. doi:http://doi.org/10.3390/nu9050437.
Ceriello A. Ihnat MA, Thorpe JE. J Clin Endocrinol Metab. 2009; 94(2): 410-415. https://doi.org/10.1210/jc. 2008-1824.
Freckmann G, Schmid C, Baumstark A, et al. J Diabetes Sci Technol. 2012; 6(5): 1060-1075. doi: http://doi.org/ 10.1177/193229681200600510.
Vitebskaja AV. Medicinskij Sovet 2016; 7: 124-127.
Thawabi M, Studyvin S. N Am J Med Sci. 2015; 7(6): 291-294. doi: http://doi.org/10.4103/1947-2714.157490.
Kumar K, Mehershahi S, Chime C, et al. Case Rep Gastroenterol. 2018; 12(2): 466-472. doi: http://doi.org/10.1159/ 000492205.
Wang Y, Desai M, Ryan PB, et al. Diabetes Res Clin Pract. 2017; 128: 83-90. doi: http://doi.org/10.1016/j.diabres.2017.04. 004.